Inel Pharmaceutical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Net Worth 6652.80%
- Total Assets 35452.80%
About Inel Pharmaceutical Systems
Inel Pharmaceutical Systems Private Limited (IPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 June 2015 (Nine years and eight months 10 days old ). Its registered office is in Pune, Maharashtra.
The Corporate was formerly known as Behere Advisory Services Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Crt Cencelj and Ivan Cencelj serve as directors at the Company.
Company Details
- Location Pune, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U31100PN2015PTC155409
- Company No.
155409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2015
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Inel Pharmaceutical Systems?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Crt Cencelj  | Director | 24-May-2016 | Current |
| Ivan Cencelj | Director | 24-May-2016 | Current |
Financial Performance of Inel Pharmaceutical Systems.
Inel Pharmaceutical Systems Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 6652.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inel Pharmaceutical Systems?
In 2017, Inel Pharmaceutical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inel Pharmaceutical Systems?
Unlock and access historical data on people associated with Inel Pharmaceutical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inel Pharmaceutical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inel Pharmaceutical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
